Last SFr.276.50 CHF
Change Today +0.70 / 0.25%
Volume 598.1K
ROG On Other Exchanges
SIX Swiss Ex
SIX Swiss Ex
As of 10:13 AM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for roche holding ag-genusschein (ROG)

Although debt as a percent of total capital decreased at Roche Holding AG over the last fiscal year to 46.82%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 67.23 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 169.39 days.
View Balance Sheet In Swiss Franc
Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Cash and Equivalents1,970.64,125.24,848.84,281.5
Short-Term Investments10,352.77,956.110,126.98,493.5
Trading Asset Securities--
TOTAL CASH AND SHORT TERM INVESTMENTS12,323.312,091.014,981.012,777.1
Accounts Receivable9,799.310,293.89,939.59,229.9
Notes Receivable239.8162.7150.9150.9
Other Receivables262.21,414.01,462.11,403.3
TOTAL RECEIVABLES10,301.311,870.511,552.610,784.1
Prepaid Expenses494.5410.0450.6449.6
Other Current Assets1,114.3431.4662.6884.1
TOTAL CURRENT ASSETS29,555.330,219.033,578.931,216.6
Gross Property Plant and Equipment33,168.933,248.133,450.433,662.4
Accumulated Depreciation-15,262.5-15,906.9-16,964.5-16,793.2
NET PROPERTY PLANT AND EQUIPMENT17,906.417,341.216,486.016,869.2
Long-Term Investments338.2327.5220.5236.6
Accounts Receivable, Long Term80.337.522.512.8
Loans Receivable, Long Term9.66.412.812.8
Deferred Tax Assets, Long Term2,534.72,956.45,190.35,038.3
Other Intangibles5,494.35,486.84,510.64,221.6
Other Long-Term Assets1,130.31,140.01,341.21,286.6
TOTAL ASSETS65,314.665,909.769,369.266,542.3
Accounts Payable1,221.31,298.41,722.21,905.3
Accrued Expenses6,847.27,321.47,898.37,913.3
Short-Term Borrowings177.71,093.9346.8751.4
Current Portion of Long-Term Debt/Capital Lease2,178.22,538.96,856.91,688.0
Current Portion of Capital Lease Obligations15.018.220.321.4
Current Income Taxes Payable2,180.42,361.32,365.51,932.0
Other Current Liabilities, Total2,937.12,337.72,274.62,321.7
Unearned Revenue, Current490.2399.3167.0357.5
TOTAL CURRENT LIABILITIES16,032.217,350.921,631.316,869.2
Long-Term Debt29,577.824,887.418,920.017,409.7
Capital Leases239.8222.6196.9169.1
Minority Interest2,347.32,555.02,393.42,084.0
Unearned Revenue, Non-Current79.267.4106.0110.2
Pension & Other Post-Retirement Benefits4,879.95,908.57,739.96,488.6
Deferred Tax Liability Non-Current947.3646.51,495.31,372.2
Other Non-Current Liabilities1,075.71,325.11,350.81,387.2
TOTAL LIABILITIES52,831.850,408.551,440.343,806.4
Common Stock171.3171.3171.3171.3
Retained Earnings15,574.018,480.121,451.527,447.8
Comprehensive Income and Other-5,609.9-5,705.1-6,087.3-6,967.1
TOTAL COMMON EQUITY10,135.412,946.215,535.520,651.9
TOTAL EQUITY12,482.815,501.217,928.922,735.9
TOTAL LIABILITIES AND EQUITY65,314.665,909.769,369.266,542.3

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.276.60 CHF +0.80

ROG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $25.98 USD +0.055
Gilead Sciences Inc $102.79 USD +1.80
Merck & Co Inc $59.40 USD -0.12
Novartis AG SFr.87.75 CHF -0.35
Pfizer Inc $29.81 USD -0.1066
View Industry Companies

Industry Analysis


Industry Average

Valuation ROG Industry Range
Price/Earnings 20.9x
Price/Sales 4.5x
Price/Book 12.7x
Price/Cash Flow 17.0x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at